EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Dysregulation of RNA-Exosome machinery is directly linked to major cancer hallmarks in prostate cancer: Oncogenic role of PABPN1

Prudencio Sáez-Martínez, Francisco Porcel-Pastrana, Antonio J Montero-Hidalgo, Samanta Lozano de la Haba, Rafael Sanchez-Sanchez, Teresa González-Serrano, Enrique Gómez-Gómez, Antonio J Martínez-Fuentes, Juan M Jiménez-Vacas, Manuel D Gahete, Raúl M Luque

Cancer Letters · 2024

DOI: 10.1016/j.canlet.2023.216604 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2024. Verfasst von Prudencio Sáez-Martínez und 10 weiteren Autor:innen. Beteiligte Einrichtung: Maimonides Institute for Biomedical Research of Córdoba (IMIBIC), Cordoba, Spain; Department of Cell Biology, Physiology, and Immunology, University …. Hauptthemen laut MEDLINE: Exosomes, Prostatic Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Junta de Andalucía, Centro de Investigación Biomédica en Red-Fisiopatología de la Obesidad y Nutrición, University of Cordoba.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Novel biomarkers and therapeutic strategies for prostate-cancer (PCa) are required to overcome its lethal progression. The dysregulation/implication of the RNA-Exosome-complex (REC; cellular machinery controlling the 3'-5'processing/degradation of most RNAs) in different cancer-types, including PCa, is poorly known. Herein, different cellular/molecular/preclinical approaches with human PCa-samples (tissues and/or plasma of 7 independent cohorts), and in-vitro/in-vivo PCa-models were used to comprehensively characterize the REC-profile and explore its role in PCa. Moreover, isoginkgetin (REC-inhibitor) effects were evaluated on PCa-cells. We demonstrated a specific dysregulation of the REC-components in PCa-tissues, identifying the Poly(A)-Binding-Protein-Nuclear 1 (PABPN1) factor as a critical regulator of major cancer hallmarks. PABPN1 is consistently overexpressed in different human PCa-cohorts and associated with poor-progression, invasion and metastasis. PABPN1 silencing decreased relevant cancer hallmarks in multiple PCa-models (proliferation/migration/tumourspheres/colonies, etc.) through the modulation of key cancer-related lncRNAs (PCA3/FALEC/DLEU2) and mRNAs (CDK2/CDK6/CDKN1A). Plasma PABPN1 levels were altered in patients with metastatic and tumour-relapse. Finally, pharmacological inhibition of REC-activity drastically inhibited PCa-cell aggressiveness. Altogether, the REC is drastically dysregulated in PCa, wherein this novel molecular event/mechanism, especially PABPN1 alteration, may be potentially exploited as a novel prognostic and therapeutic tool for PCa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesProstatic NeoplasmsMaleHumansExosome Multienzyme Ribonuclease ComplexCell Line, TumorGene Expression Regulation, NeoplasticNeoplasm Recurrence, LocalRNA, MessengerPoly(A)-Binding Protein I

Stichwörter der Autor:innen

BiomarkersPABPN1Prostate cancerRNA-ExosomeTherapeutic targets

Substanzen

Exosome Multienzyme Ribonuclease ComplexRNA, MessengerPABPN1 protein, humanPoly(A)-Binding Protein I

Autor:innen und Institutionen

  • Maimonides Institute for Biomedical Research of Córdoba (IMIBIC), Cordoba, Spain; Department of Cell Biology, Physiology, and Immunology, University of Córdoba, Cordoba, Spain; Hospital Universitario Reina Sofía (HURS),…
  • Maimonides Institute for Biomedical Research of Córdoba (IMIBIC), Cordoba, Spain; Hospital Universitario Reina Sofía (HURS), Cordoba, Spain; Anatomical Pathology Service, HURS, Cordoba, Spain.
  • Maimonides Institute for Biomedical Research of Córdoba (IMIBIC), Cordoba, Spain; Hospital Universitario Reina Sofía (HURS), Cordoba, Spain; Urology Service, HURS/IMIBIC, Cordoba, Spain.
  • Institute of Cancer Research, London, UK.

Förderung

  • Junta de Andalucía
  • Centro de Investigación Biomédica en Red-Fisiopatología de la Obesidad y Nutrición
  • University of Cordoba
  • Instituto de Salud Carlos III
  • Ministerio de Ciencia, Innovación y Universidades

Zitieren

APA

Sáez-Martínez, P., Porcel-Pastrana, F., Montero-Hidalgo, A. J., Lozano de la Haba, S., Sanchez-Sanchez, R., González-Serrano, T., Gómez-Gómez, E., Martínez-Fuentes, A. J., Jiménez-Vacas, J. M., Gahete, M. D., & Luque, R. M. (2024). Dysregulation of RNA-Exosome machinery is directly linked to major cancer hallmarks in prostate cancer: Oncogenic role of PABPN1. Cancer Letters. https://doi.org/10.1016/j.canlet.2023.216604

Vancouver

Sáez-Martínez P, Porcel-Pastrana F, Montero-Hidalgo AJ, Lozano de la Haba S, Sanchez-Sanchez R, González-Serrano T, et al. Dysregulation of RNA-Exosome machinery is directly linked to major cancer hallmarks in prostate cancer: Oncogenic role of PABPN1. Cancer Letters. 2024. doi:10.1016/j.canlet.2023.216604

BibTeX
@article{SezMartnez2024,
  author = {Sáez-Martínez, Prudencio and Porcel-Pastrana, Francisco and Montero-Hidalgo, Antonio J and Lozano de la Haba, Samanta and Sanchez-Sanchez, Rafael and González-Serrano, Teresa and Gómez-Gómez, Enrique and Martínez-Fuentes, Antonio J and Jiménez-Vacas, Juan M and Gahete, Manuel D and Luque, Raúl M},
  title = {Dysregulation of RNA-Exosome machinery is directly linked to major cancer hallmarks in prostate cancer: Oncogenic role of PABPN1},
  journal = {Cancer Letters},
  year = {2024},
  doi = {10.1016/j.canlet.2023.216604}
}
Kostenlos starten →